Bridgefront Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,610
Closed -$293K 707
2025
Q3
$293K Buy
+9,610
New +$295K 0.09% 404
2025
Q2
Sell
-6,251
Closed -$219K 779
2025
Q1
$219K Buy
+6,251
New +$248K 0.06% 491
2024
Q4
Sell
-4,848
Closed -$211K 729
2024
Q3
$211K Buy
+4,848
New +$183K 0.08% 442
2023
Q4
Sell
-6,032
Closed -$272K 513
2023
Q3
$272K Buy
+6,032
New +$365K 0.19% 228
2022
Q4
Sell
-3,346
Closed -$291K 477
2022
Q3
$291K Buy
+3,346
New +$352K 0.3% 141
2022
Q1
Sell
-1,845
Closed -$333K 385
2021
Q4
$333K Buy
+1,845
New +$320K 0.32% 122
2021
Q2
Sell
-3,848
Closed -$500K 816
2021
Q1
$500K Buy
+3,848
New +$494K 0.16% 234

Other funds holding OMCL

Bridgefront Capital's OMCL Position: Q4 2025 in Review

Bridgefront Capital sold out of Omnicell (OMCL) in Q4 2025, closing a stake of 9,610 shares — an estimated $293K sold.

Bridgefront Capital first reported a position in OMCL in Q1 2021 and held it in 7 quarters. The position peaked at $500K in Q1 2021. 262 funds tracked by Wall St. Rank hold OMCL as of Q4 2025.

  • Bridgefront Capital reported no remaining Omnicell position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 9,610 Omnicell shares in Q4 2025, an estimated $293K.
  • Bridgefront Capital first reported a position in Omnicell in Q1 2021 and held it in 7 quarters.
  • Bridgefront Capital's Omnicell position peaked at $500K in Q1 2021.
  • 262 funds tracked by Wall St. Rank held Omnicell as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.